<ddi:DDIInstance xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:instance:3_3 http://ddialliance.org/Specification/DDI-Lifecycle/3.3/XMLSchema/instance.xsd" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ddi="ddi:instance:3_3" xmlns:r="ddi:reusable:3_3" xmlns:s="ddi:studyunit:3_3" xmlns:d="ddi:datacollection:3_3" xmlns:a="ddi:archive:3_3" xmlns:c="ddi:conceptualcomponent:3_3" xmlns:cm="ddi:comparative:3_3" xmlns:g="ddi:group:3_3" xmlns:l="ddi:logicalproduct:3_3" xmlns:p="ddi:physicaldataproduct:3_3" xmlns:pi="ddi:physicalinstance:3_3" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace" isMaintainable="true" scopeOfUniqueness="Agency">
  <r:URN>urn:ddi:se.researchdata:2024-144:1</r:URN>
  <r:Agency>SND</r:Agency>
  <r:ID>2024-144</r:ID>
  <r:Version>1</r:Version>
  <g:ResourcePackage>
    <r:URN>urn:ddi:se.researchdata:2024-144.ResourcePackage:2.0</r:URN>
    <r:OtherMaterialScheme>
      <r:URN>urn:ddi:se.researchdata:2024-144.OtherMaterialScheme:2.0</r:URN>
    </r:OtherMaterialScheme>
    <a:OrganizationScheme>
      <r:URN>urn:ddi:se.researchdata:2024-144.OrganizationScheme-0:2.0</r:URN>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:2024-144.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Department of Information Technology, Uppsala University</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Eduard</a:FirstGiven>
            <a:LastFamily>Chelebian</a:LastFamily>
            <a:FullName>
              <r:String>Eduard Chelebian</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0001-6852-6605</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:2024-144.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Department of Information Technology, Uppsala University</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Carolina</a:FirstGiven>
            <a:LastFamily>Wählby</a:LastFamily>
            <a:FullName>
              <r:String>Carolina Wählby</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0002-4139-7003</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:2024-144.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Department of Medical Biosciences, Umeå University</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Anders</a:FirstGiven>
            <a:LastFamily>Bergh</a:LastFamily>
            <a:FullName>
              <r:String>Anders Bergh</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0001-5163-5821</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
    </a:OrganizationScheme>
  </g:ResourcePackage>
  <s:StudyUnit>
    <r:URN>urn:ddi:se.researchdata:2024-144.StudyUnit:2.0</r:URN>
    <r:UserID typeOfUserID="datasetIdentifier">2024-144</r:UserID>
    <r:Citation>
      <r:Title>
        <r:String xml:lang="sv">Undetected cancer in clinical prostate biopsies</r:String>
        <r:String xml:lang="en">Undetected cancer in clinical prostate biopsies</r:String>
      </r:Title>
      <r:Creator>
        <r:CreatorReference>
          <r:URN>urn:ddi:se.researchdata:2024-144.Individual-0:2.0</r:URN>
          <r:TypeOfObject>Individual</r:TypeOfObject>
        </r:CreatorReference>
      </r:Creator>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Uppsala universitet</r:String>
          <r:String xml:lang="en">Uppsala University</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Uppsala universitet</r:String>
          <r:String xml:lang="en">Uppsala University</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:PublicationDate>
        <r:SimpleDate>2024-06-17</r:SimpleDate>
      </r:PublicationDate>
      <r:InternationalIdentifier>
        <r:IdentifierContent>10.57804/epa0-8v59</r:IdentifierContent>
        <r:ManagingAgency controlledVocabularyAgencyName="DOI">DOI</r:ManagingAgency>
      </r:InternationalIdentifier>
    </r:Citation>
    <r:Abstract>
      <r:Content xml:lang="sv">Datasetet består av digitiserade godartade prostata H&amp;E-biopsier från män med förhöjda PSA-värden. För mer information, se beskrivning på engelska:

This dataset comprises digitized benign prostate hematoxilyn and eosin (H&amp;E) biopsies from men with raised prostate-specific antigen (PSA) values. The biopsies were systematically taken from different locations in the prostate and were not guided by magnetic resonance imaging (MRI). The dataset includes paired samples from patients with comparable age and PSA levels, all initially diagnosed as benign but with different outcomes upon subsequent follow-ups and re-biopsies. While some patients remained cancer-free during eight years of follow-up, others were diagnosed with prostate cancer within the subsequent 30 months of follow-up. 
The final processed dataset includes 213 patients from northern Sweden, resulting in a total of 587 H&amp;E prostate needle biopsies. Among these, 125 control patients with 333 biopsies exhibited no cancer development in eight years following the initial diagnosis. Conversely, 88 case patients with 254 biopsies were diagnosed with PCa of various ISUP grades within the 30 months following the initial diagnosis. Each case patient is accompanied by one to three control patients, paired for similar age, PSA value and year of diagnosis. 
Patients were anonymized by assigning random case IDs and MRXS image files were anonymized by using the module in https://github.com/bgilbert/anonymize-slide.</r:Content>
      <r:Content xml:lang="en">This dataset comprises digitized benign prostate hematoxilyn and eosin (H&amp;E) biopsies from men with raised prostate-specific antigen (PSA) values. The biopsies were systematically taken from different locations in the prostate and were not guided by magnetic resonance imaging (MRI). The dataset includes paired samples from patients with comparable age and PSA levels, all initially diagnosed as benign but with different outcomes upon subsequent follow-ups and re-biopsies. While some patients remained cancer-free during eight years of follow-up, others were diagnosed with prostate cancer within the subsequent 30 months of follow-up. 
The final processed dataset includes 213 patients from northern Sweden, resulting in a total of 587 H&amp;E prostate needle biopsies. Among these, 125 control patients with 333 biopsies exhibited no cancer development in eight years following the initial diagnosis. Conversely, 88 case patients with 254 biopsies were diagnosed with prostate cancer of various ISUP grades within the 30 months following the initial diagnosis. Each case patient is accompanied by one to three control patients, paired for similar age, PSA value and year of diagnosis. 
Patients were anonymized by assigning random case IDs and MRXS image files were anonymized by using the module in https://github.com/bgilbert/anonymize-slide.</r:Content>
    </r:Abstract>
    <r:Coverage>
      <r:TopicalCoverage>
        <r:URN>urn:ddi:se.researchdata:2024-144.TopicalCoverage:2.0</r:URN>
        <r:Subject xml:lang="en" controlledVocabularyID="ScienceAndTechnology" controlledVocabularyName="CESSDA Topic Classification">SCIENCE AND TECHNOLOGY</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="ScienceAndTechnology" controlledVocabularyName="CESSDA Topic Classification">VETENSKAP OCH TEKNOLOGI</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="ScienceAndTechnology.InformationTechnology" controlledVocabularyName="CESSDA Topic Classification">Information technology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="ScienceAndTechnology.InformationTechnology" controlledVocabularyName="CESSDA Topic Classification">Informationsteknik</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="10207" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Computer graphics and computer vision</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="10207" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Datorgrafik och datorseende</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="20603" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medical Imaging</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="20603" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medicinsk bildvetenskap</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="3" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medical and Health Sciences</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="3" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medicin och hälsovetenskap</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30203" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cancer and Oncology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30203" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cancer och onkologi</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30228" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Urology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30228" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Urologi</r:Subject>
        <r:Keyword xml:lang="en" controlledVocabularyID="urn:ddi:int.cessda.elsst:88613e8a-3055-4ff2-84c2-750a111c4372:4" controlledVocabularyName="ELSST">PATHOLOGY</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="urn:ddi:int.cessda.elsst:88613e8a-3055-4ff2-84c2-750a111c4372:4" controlledVocabularyName="ELSST">PATOLOGI</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D006652" controlledVocabularyName="MeSH">Histological Techniques</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D006652" controlledVocabularyName="MeSH">Histologiska tekniker</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D007091" controlledVocabularyName="MeSH">Image Processing, Computer-Assisted</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D007091" controlledVocabularyName="MeSH">Datorstödd bildbehandling</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D009370" controlledVocabularyName="MeSH">Neoplasms by Histologic Type</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D009370" controlledVocabularyName="MeSH">Tumörer, histologisk typ</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D013194" controlledVocabularyName="MeSH">Staining and Labeling</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D013194" controlledVocabularyName="MeSH">Färgning och märkning</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D017430" controlledVocabularyName="MeSH">Prostate-Specific Antigen</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D017430" controlledVocabularyName="MeSH">Prostataspecifikt antigen</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D019295" controlledVocabularyName="MeSH">Computational Biology</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D019295" controlledVocabularyName="MeSH">Beräkningsbiologi</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="C61" controlledVocabularyName="ICD-10">Malignant neoplasm of prostate</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="C61" controlledVocabularyName="ICD-10">Malign tumör i prostata</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D291" controlledVocabularyName="ICD-10">Benign neoplasm: Prostate</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D291" controlledVocabularyName="ICD-10">Benign tumör i prostata</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="urn:ddi:int.cessda.elsst:3413ed2c-aab5-4565-96f0-77b444c05ad8:4" controlledVocabularyName="ELSST">PROSTATE CANCER SCREENING</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="urn:ddi:int.cessda.elsst:3413ed2c-aab5-4565-96f0-77b444c05ad8:4" controlledVocabularyName="ELSST">SCREENING FÖR PROSTATACANCER</r:Keyword>
      </r:TopicalCoverage>
      <r:SpatialCoverage />
      <r:TemporalCoverage>
        <r:URN>urn:ddi:se.researchdata:2024-144.TemporalCoverage:2.0</r:URN>
        <r:ReferenceDate>
          <r:StartDate>1997</r:StartDate>
          <r:EndDate>2016</r:EndDate>
        </r:ReferenceDate>
      </r:TemporalCoverage>
    </r:Coverage>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">Individual<r:ControlledVocabularyURN>http://rdf-vocabulary.ddialliance.org/cv/AnalysisUnit/2.1.3/2dd4472</r:ControlledVocabularyURN></r:AnalysisUnit>
    <r:AnalysisUnitsCovered>
      <r:String xml:lang="en">Individual</r:String>
      <r:String xml:lang="sv">Individ</r:String>
    </r:AnalysisUnitsCovered>
    <d:DataCollection>
      <r:URN>urn:ddi:se.researchdata:2024-144.DataCollection:2.0</r:URN>
      <d:CollectionEvent>
        <r:URN>urn:ddi:se.researchdata:2024-144.CollectionEvent:2.0</r:URN>
        <d:DataCollectorOrganizationReference>
          <r:URN>urn:ddi:se.researchdata:2024-144.Organization-0:2.0</r:URN>
          <d:ID />
          <d:Version />
          <d:TypeOfObject>Organization</d:TypeOfObject>
        </d:DataCollectorOrganizationReference>
        <d:DataCollectionDate />
        <d:ModeOfCollection>
          <r:URN>urn:ddi:se.researchdata:2024-144.CollectionEvent-0-ModeOfCollectionType:2.0</r:URN>
          <d:TypeOfModeOfCollection>Registry extract and/or access to biobank sample</d:TypeOfModeOfCollection>
          <r:Description>
            <r:Content xml:lang="en">Registry extract and/or access to biobank sample</r:Content>
            <r:Content xml:lang="sv">Registerutdrag och/eller tillgång till prov i biobank</r:Content>
          </r:Description>
        </d:ModeOfCollection>
      </d:CollectionEvent>
    </d:DataCollection>
    <a:Archive>
      <r:URN>urn:ddi:se.researchdata:2024-144.Archive:2.0</r:URN>
      <a:ArchiveSpecific>
        <a:Item>
          <a:Access>
            <r:URN>urn:ddi:se.researchdata:2024-144.Archive-ArchiveSpecificType-AccessType:2.0</r:URN>
            <a:TypeOfAccess controlledVocabularyName="info:eu-repo-Access-Terms vocabulary">openAccess</a:TypeOfAccess>
          </a:Access>
          <a:DataFileQuantity>9</a:DataFileQuantity>
        </a:Item>
      </a:ArchiveSpecific>
    </a:Archive>
  </s:StudyUnit>
</ddi:DDIInstance>